VTAK: Catheter Precision Inc Net Margin

Catheter Precision attracts biomedical engineers and electrophysiology experts, fostering a culture of saving lives through high-tech developments. This chart of commercial profitability levels is available in the GURU.Markets system, with a value maintained at -711.50. The VIVO IT system for precise 3D mapping of arrhythmias provides a competitive advantage. The business relies on contract electronics manufacturing and external outsourcing for conducting clinical trials.
Summary analytical data breakdowns for Catheter Precision Corporation (VTAK)

This indicator determines the efficiency of converting revenue into net income. The net profit margin trend visualizes the actual return on invested capital, smoothing out market expectations. The metric is calculated as the ratio of final profit to total sales volume as a percentage. A stable trend confirms the high added value of VIVO technologies. Surgeons' confidence in the 3D mapping provided by Catheter Precision (VTAK) ensures the sustainability of this profitability.